Cyclosporine and Prognosis in Acute Myocardial Infarction (MI) Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 970 participants.

Also called NCT01502774

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 970 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01502774
Other papers using this trial's data
  • Cyclosporine before PCI in Patients with Acute Myocardial Infarction The New England journal of medicine, 2015-09-10 DOI, PubMed 26321103
  • Importance of infarct size versus other variables for clinical outcomes after PPCI in STEMI patients Basic research in cardiology, 2019-12-12 DOI, PubMed 31832789

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, France, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01502774. Randomized; quadruple masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2015-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cyclosporine and Prognosis in Acute Myocardial Infarction (MI) Patients
Acronym
CIRCUS
Condition
ST Elevation Acute Myocardial Infarction
Intervention (Drug)
Injection of Cyclosporin
Intervention (Drug)
Placebo
Intervention (Procedure)
Echocardiography
Lead sponsor
Hospices Civils de Lyon (class: other)

Record details

Record id
cardio:ct-nct01502774
Content hash
c7237746d77254ddb5f613a959a1588ad15fe00a3cbd79fb132175e32e093beb